A severe form of autosomal recessive spinocerebellar ataxia associated with novel PMPCA variants

• Published in: Brain & development (Tokyo. 1979) Vol. 43; no. 3; pp. 464 - 469
• Main Authors: Takahashi, Yoko, Kubota, Masaya, Kosaki, Rika, Kosaki, Kenjiro, Ishiguro, Akira
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 01.03.2021
• Subjects: Adolescent; Brain - pathology; Cerebellar ataxia; Cerebellar atrophy; Female; Frataxin; Genotype; Humans; Iron-Binding Proteins - genetics; Mitochondrial processing peptidase; Mutation; Neurodegeneration with brain iron accumulation; Pedigree; Phenotype; PMPCA; Spinocerebellar Degenerations - genetics; Spinocerebellar Degenerations - pathology; Cerebellar atrophy; Neurodegeneration with brain iron accumulation; PMPCA; Mitochondrial processing peptidase; Frataxin; Cerebellar ataxia
• ISSN: 0387-7604; 1872-7131
• DOI: 10.1016/j.braindev.2020.11.008

Spinocerebellar ataxia, autosomal recessive 2 (SCAR2) [MIM:213200] is a rare autosomal recessive disease of spinocerebellar ataxia associated with degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCAR2 is characterized by onset of impaired motor development and ataxic gait in early childhood. Recently, several PMPCA gene variants have been reported in SCAR2 patients with mild and non-progressive symptoms. PMPCA codes frataxin, which is crucial for iron biosynthesis in cells. We report a case of a 15-year-old Japanese girl with infancy-onset, very severe and progressive developmental delay, cerebellar ataxia, and extrapyramidal symptoms. Brain magnetic resonance imaging showed cerebellar atrophy and excessive brain iron accumulation in the bilateral globus pallidi and substantia nigra. Based on the clinical phenotypes and imaging, neurodegeneration with brain iron accumulation was suspected. Whole-exome sequencing on the proband and her parents revealed novel compound heterozygous variants at c.667C > T (p.Arg223Cys) and c.853del (p.Asp285llefs*16) in PMPCA. Thus, her disease was diagnosed as SCAR2. Phenotype in our case was different from ones previously reported for SCARs in the points of much severer clinical presentations with extrapyramidal signs and imaging suspected iron accumulation, and might overlap neurodegeneration with brain iron accumulation or NBIA subtypes. Our case might provide a new insight into PMPCA gene-related disorders and expand the disease concept.